United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 18, 2026 · Filed Sep 21, 2026

On Sep 18, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$494.79 for US$4.7M under a trading plan, leaving 324,443 shares. Filed Sep 21, 2026 (Form 4).

Sold
9,500 shares
Price
US$494.79 average (US$492.91 to US$498.25)
Value
US$4.7M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 18, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 18, 2026Common StockSale248US$492.91333,695Indirect
Sep 18, 2026Common StockSale2,216US$493.78331,479Indirect
Sep 18, 2026Common StockSale4,269US$494.70327,210Indirect
Sep 18, 2026Common StockSale2,330US$495.66324,880Indirect
Sep 18, 2026Common StockSale277US$496.64324,603Indirect
Sep 18, 2026Common StockSale160US$498.25324,443Indirect

Source

View original at SEC

Related